Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
precisionmedicineonline
20h
Achilles Therapeutics Shuts Down Engineered Cell Therapy Program, Explores Cost-Cutting Measures
The firm is discontinuing its CHIRON and THETIS trials after lackluster data and is planning for potential third-party deals and workforce layoffs.
precisionmedicineonline
23h
Janssen's Rybrevant, Chemo Regimen Nets FDA Approval in EGFR-Mutated NSCLC
The agency reviewed data from the MARIPOSA-2 trial and approved the regimen for patients with common EGFR mutations who are progressing on EGFR inhibitors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Secret Service admits failure
Released after guilty plea
Jurors begin deliberations
Sesame Place suit verdict
Pandas leaving for China
SC 1st execution in 13 years
Drug price challenge revived
Boeing defense chief exits
TN abortion law blocked
Feds subpoena Schaeffer
Russia threatens retaliation
WI high court to decide
FDA approves flu vaccine
Lebanon: 31 dead in strike
144K+ Mavericks recalled
Hand count approved in GA
Body found in SUV
House repeals emission rules
Bill to boost security OK'd
Sues pharmacy middlemen
$230 million crypto theft
Top Hezbollah leader killed?
In-person voting begins
Baby powder recalled
Hiker injured in bear attack
1st rabies outbreak in seals
Stein's ballot bid rejected
MS sheriff's office probe
Recalling 449K+ vehicles
Disney to stop using Slack
$3B for battery projects
Feedback